Patents/Assignees

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED

20 patents in portfolio

US12616705utility2026
Use of Cannabinoids in the Treatment of Angelman Syndrome
0 cites
US12569505utility2026
Oral Solid Dosage Forms Comprising Cannabinoids
0 cites
US12558362utility2026
Use of Cannabidiol in the Treatment of Seizures Associated with Rett Syndrome
0 cites
US12539472utility2026
Method of Preparing Cannabinoids
0 cites
US12534438utility2026
Cannabinoid Derivative as a Pharmaceutically Active Compound and Method of Preparation Thereof
0 cites
US12427160utility2025
Use of Cannabinoids in the Treatment of Epilepsy
0 cites
US12403136utility2025
Cannabinoid Derivatives as Pharmaceutically Active Compounds and Methods of Preparation Thereof
0 cites
US12396963utility2025
Cannabidiol-type Cannabinoid Compound
0 cites
US12383512utility2025
Cannabidiol-type Cannabinoid Compound
0 cites
US12383567utility2025
Use of Cannabinoids in the Treatment of Epilepsy
0 cites
US12364670utility2025
Cannabidiol-type Cannabinoid Compound
0 cites
US12357586utility2025
Use of the Phytocannabinoid Cannabidiol (CBD) in Combination with a Standard Anti-epileptic Drug (SAED) in the Treatment of Epilepsy
0 cites
US12350253utility2025
Use of Cannabinoids in the Treatment of Dyskinesia Associated with Parkinson's Disease
0 cites
US12318356utility2025
Use of Cannabinoids in the Treatment of Epilepsy
0 cites
US12263139utility2025
Use of Cannabidiol in the Treatment of Tuberous Sclerosis Complex
0 cites
US12213985utility2025
Oral Cannabinoid Formulations
0 cites
US12161607utility2024
Combination of Cannabinoids in the Treatment of Leukemia
0 cites
US12102619utility2024
Methods of Treating Tuberous Sclerosis Complex with Cannabidiol and Everolimus
0 cites
US12064398utility2024
Parenteral Formulations
0 cites
US12064399utility2024
Use of Cannabinoids in the Treatment of Epilepsy
0 cites